All things STOCKS

I like their business. I don’t like Dan Gilbert. He already went public once and then took RKT private at nearly 10 cents on the dollar. I wouldn’t put it past him to pull that chit again.

The business is well positioned without the expensive bricks and mortar offices to profitably sell lots of mortgages to home buyers under 35. Unfortunately housing has gotten really expensive for that demo. It’s a good buy and hold if Dan Gilbert can be trusted.
 
If GOOG implements the same privacy settings as Apple, Fb and Shopify are f*cked. I held off on purchasing SHOP at open and I'm glad I did now.
 
This is a buying opportunity for SHOP imo.
Set a calendar reminder for 6 months and check it again. These things bleed out - the day after the earnings report usually isn't the low or even close to the low. Even if it bounces like NFLX, these things need to settle in. NFLX is back trading below where it closed the day after the earnings report.
 
  • Like
Reactions: mrorange211
I think that kind of conversation needs to be in a group comprised entirely of deluded people. That's just one man's opinion.
 
SHOP makes some of their money from the merchant process provided by FB. Their businesses are connected in that way. It wouldn't take down SHOP but it would hurt its margins.

I think that it is extremely disruptive to Facebook. They have been able to charge a huge premium for their ads targeted and delivered to precise demos. They even changed their name to Meta (metadata). It will be a slow burn of the data that they collect on their users as they get replacement phones and FB loses the ability to keep charging customers those huge premiums for the customized ad distribution. However they will always be able to direct the ads at specific geographic regions and genders and (possibly) ages. Also the FB users do share their interests by following certain pages.
 
Dow down another 400 today. These low waves are a good buy time bit concerning for those looking to retire in the next few months to two years.
 
  • Like
Reactions: tbh
3M is creating a partial vacuum, and has since the new year...supply chain woes and lawsuits will do that, though. Dunno whether I want to sit tight and see what happens, or eat the loss and reposition into something else (like AbbVie).
 
3M is creating a partial vacuum, and has since the new year...supply chain woes and lawsuits will do that, though. Dunno whether I want to sit tight and see what happens, or eat the loss and reposition into something else (like AbbVie).

MMM is a great American company. They have highly diversified revenue streams with many products and customers and they are the kind of things that are purchased repeatedly. I would suspect that they are highly positively correlated to general economic conditions but are pretty safe in downturns. I’d be interested in what percentage health care is in their product mix. No doubt they’ve had a bit of a windfall in PPE. I’d also be curious how dependent they are on China for manufacturing.
 
  • Like
Reactions: tbh
MMM is a great American company. They have highly diversified revenue streams with many products and customers and they are the kind of things that are purchased repeatedly. I would suspect that they are highly positively correlated to general economic conditions but are pretty safe in downturns. I’d be interested in what percentage health care is in their product mix. No doubt they’ve had a bit of a windfall in PPE. I’d also be curious how dependent they are on China for manufacturing.

They're currently having some problems with hearing protection lawsuits tied to a US military contract, and the demand for masks is waning for the time being from what I have read. I do recall several articles from back during the height of the pandemic mentioning they were trying to increase their manufacturing capabilities here in the US, but I'm not sure how much progress was made to that end. I'm curious whether the supply chain concerns are linked more to base materials or finished product. I like their dividend payout as well...which is consequently around the same level as AbbVie, which I also hold. I think I need to settle down and ride it out, haha.
 
They're currently having some problems with hearing protection lawsuits tied to a US military contract, and the demand for masks is waning for the time being from what I have read. I do recall several articles from back during the height of the pandemic mentioning they were trying to increase their manufacturing capabilities here in the US, but I'm not sure how much progress was made to that end. I'm curious whether the supply chain concerns are linked more to base materials or finished product. I like their dividend payout as well...which is consequently around the same level as AbbVie, which I also hold. I think I need to settle down and ride it out, haha.

I’d be more worried about ABBV. I owned it briefly for a little trade last year. Next time I’m in a biotech name it will probably be an ETF to spread out risk.

I wouldn’t worry about lawsuits against MMM. That’s, unfortunately, just part of doing business. I’m sure that they’re really good at managing their risk.

PPE is a nice business for them but is probably less than 1%. I bet that they sell all sorts of supplies of many types to hospitals and the hospital business has been booming for a couple of years. Demos are favorable for health care to continue to thrive. I also own some Stericycle (SCRL) expecting them to do well with the spent supplies going out the back door. Perhaps they were stuck in long term agreements that weren’t favorable for them with the pandemic spike. They also had some sort of management screw up before COVID was even around. Waste Management (WM) has been a much better position for me, although I’ve been long with it for several more years.
 
  • Like
Reactions: tbh
I'm getting ready to buy into some ARK funds, specifically K and G. They have hit bottom or close, imo, and I do like their portfolio overall.
 

VN Store



Back
Top